Perspective on biotech

Blue Latitude Health|14th September 2017

Biotech companies operate in highly complex markets with extremely challenging regulatory constraints. As a creative marketing consultancy we are well positioned to cut through this noise and tackle challenges from all angles, offering leading strategic and creative solutions. 

Ahead of our upcoming report into strategic challenges and opportunities in the sector, we have been speaking to biotech experts to find out their perspective on the state of the industry. 

Here we explore some of their enlightening insights and reveal how the definition of biotech is changing as big pharma turns its research and development to biological therapies. 

Find out about: 

  • The emerging technologies revolutionising the biotech industry – from immunotherapy breakthroughs to cutting-edge gene editing techniques
  • How to define a biotech company – is the current definition still valid?
  • Shaping the future of healthcare – solving four common challenges facing biotech companies today.

 

Mastering the precision medicine opportunity

David Cooney|16th August 2018

The rise of precision medicine will transform the pharma business model, challenging the way we commercialise therapies. BLH Senior Consultant and precision medicine expert David Cooney, reveals how you can plan for this change.

read more

What makes a mental health professional recommend a CBT app?

Natasha Cowan, Amit Sheinholtz|6th August 2018

Senior Associate UX Consultant Amit Sheinholtz was recently awarded City University’s prestigious prize for Outstanding Project of the Year. BLH caught up with him to get the inside scoop on his master’s thesis on mental health apps and what it takes to create excellent research

read more